• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Lomitapide

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information

Lomitapide

EndocrinologyLDLRHomozygous familial
hypercholesterolemia
and LDL receptor mutation
deficient
Indications and Usage
Adverse Reactions
Clinical Studies

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling